EP 2545052 B1 20141112 - IMIDAZOPYRIDINES SYK INHIBITORS
Title (en)
IMIDAZOPYRIDINES SYK INHIBITORS
Title (de)
IMIDAZOPYRIDINE ALS SYK-INHIBITOREN
Title (fr)
INHIBITEURS DE SYK À BASE D'IMIDAZOPYRIDINES
Publication
Application
Priority
- US 31277110 P 20100311
- US 31322310 P 20100312
- US 2011028194 W 20110311
Abstract (en)
[origin: WO2011112995A1] Certain imidazopyridines (I) and pharmaceutical compositions thereof are provided herein. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of Syk activity, which comprises administering to such patients an amount of at least one chemical entity effective to reduce signs or symptoms of the disease or disorder are provided. Also provided are methods for determining the presence or absence of Syk kinase in a sample.
IPC 8 full level
C07D 471/04 (2006.01); A61K 31/437 (2006.01); A61P 11/00 (2006.01); A61P 19/00 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); C07D 519/00 (2006.01)
CPC (source: EP KR US)
A61K 31/437 (2013.01 - EP KR US); A61K 31/444 (2013.01 - EP US); A61K 31/4545 (2013.01 - EP US); A61K 31/496 (2013.01 - EP US); A61K 31/498 (2013.01 - EP US); A61K 31/4985 (2013.01 - EP US); A61K 31/506 (2013.01 - EP US); A61K 31/517 (2013.01 - EP US); A61K 31/5377 (2013.01 - EP US); A61K 31/538 (2013.01 - EP US); A61K 31/5383 (2013.01 - EP US); A61K 31/69 (2013.01 - EP US); A61P 11/00 (2017.12 - EP); A61P 11/02 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 19/00 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/04 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 35/02 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 471/04 (2013.01 - EP KR US); C07D 487/04 (2013.01 - EP KR US); C07D 498/04 (2013.01 - EP KR US); C07D 519/00 (2013.01 - EP KR US); C12Q 1/485 (2013.01 - KR US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2011112995 A1 20110915; AU 2011226689 A1 20120927; AU 2011226689 B2 20160901; AU 2016219585 A1 20160908; AU 2016219585 B2 20180208; AU 2018203210 A1 20180531; BR 112012022943 A2 20180605; CA 2792769 A1 20110915; CA 2792769 C 20180522; CN 103168039 A 20130619; CN 103168039 B 20160803; EP 2545052 A1 20130116; EP 2545052 B1 20141112; ES 2530449 T3 20150302; HK 1180689 A1 20131025; JP 2013522238 A 20130613; JP 2015164938 A 20150917; JP 2017222685 A 20171221; JP 5938352 B2 20160622; JP 6177828 B2 20170809; KR 101717809 B1 20170317; KR 20130038239 A 20130417; MX 2012010418 A 20130114; MX 350010 B 20170823; NZ 602362 A 20141128; PT 2545052 E 20150218; US 10092583 B2 20181009; US 10842803 B2 20201124; US 2013210802 A1 20130815; US 2017095490 A1 20170406; US 2019117679 A1 20190425; US 9562056 B2 20170207
DOCDB simple family (application)
US 2011028194 W 20110311; AU 2011226689 A 20110311; AU 2016219585 A 20160823; AU 2018203210 A 20180508; BR 112012022943 A 20110311; CA 2792769 A 20110311; CN 201180023252 A 20110311; EP 11709600 A 20110311; ES 11709600 T 20110311; HK 13108104 A 20130710; JP 2012557294 A 20110311; JP 2015094508 A 20150505; JP 2017136797 A 20170713; KR 20127026472 A 20110311; MX 2012010418 A 20110311; NZ 60236211 A 20110311; PT 11709600 T 20110311; US 201113806094 A 20110311; US 201615387557 A 20161221; US 201816124113 A 20180906